EMBC News and Press, Embecta Corp. From 11/19/23

2023-11-19 08:00:00 ET Even with the holiday-shortened Thanksgiving week, several prominent companies are set to unveil their quarterly results next week. The docket includes tech giant Nvidia ( NASDAQ: NVDA ), as well as Zoom Video ( NASDAQ: ZM ), HP Inc. ( NYSE: HPQ ...

PARSIPPANY, N.J., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, announced it will ring the Nasdaq opening bell today, in recognition of National Diabetes Awareness Month in November. The coming year is also a time to...

PARSIPPANY, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal fourth quarter and full year 2023 financial results, and provide an operational update, including prelimina...

2023-10-17 22:00:32 ET Summary EMBC's stock has hit its lowest marks since its listing, indicating the negative sentiment in the company. The company's recent financial performance has been soft, with declining top-line numbers and hurdles to demand + pricing. The balance shee...

2023-10-17 20:30:00 ET Summary With the start of the final quarter of 2023, it’s time to take a look back at my previous month of dividend income. Getting close to that $2,000 milestone in a month sure looks amazing. I know, those end of quarter months are always the big pa...

PARSIPPANY, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in a fireside chat at the Morgan Stanley 21 st Annual Healthcare Conference in New York on Tuesday, September 12, 2023 at 2:55 p.m. ET. Audio webc...

2023-08-13 12:17:07 ET Embecta Corp. (EMBC) Q3 2023 Earnings Conference Call August 8, 2023 08:00 ET Company Participants Pravesh Khandelwal - Vice President of Investor Relations Dev Kurdikar - Chief Executive Officer Jake Elguicze - Chief Financial Officer ...

2023-08-11 06:22:38 ET Summary STAAR Surgical Company's revenue continues to grow, but its bottom line financial performance has been disappointing. The stock is trading at a very high price, making it overpriced compared to similar firms. More likely than not, the stock shoul...

2023-08-08 06:51:26 ET Embecta press release ( NASDAQ: EMBC ): Q3 Non-GAAP EPS of $0.69 beats by $0.23 . Revenue of $286.1M (-1.7% Y/Y) beats by $11.03M . U.S. revenues decreased 2.6% on both a reported and constant currency basis International revenue...

PARSIPPANY, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and nine-month periods ended June 30, 2023. "Having completed nearly a year and a...